Michelle Pacheco, Kathleen Fitzsimmons, Carolyn Reeb-Whitaker, Kenneth Rosenman, Jennifer Flattery, Justine Lew Weinberg, Mary Jo Reilly, Sarah Yiu, Coralynn Sack, Danièle Todorov, Robert Harrison, Katelynn E Dodd, Emily Sparer-Fine
{"title":"Work-Related Asthma in the Cannabis Industry: Findings From California, Massachusetts, Michigan, and Washington.","authors":"Michelle Pacheco, Kathleen Fitzsimmons, Carolyn Reeb-Whitaker, Kenneth Rosenman, Jennifer Flattery, Justine Lew Weinberg, Mary Jo Reilly, Sarah Yiu, Coralynn Sack, Danièle Todorov, Robert Harrison, Katelynn E Dodd, Emily Sparer-Fine","doi":"10.1097/JOM.0000000000003461","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>Describe work-related asthma (WRA) cases and associated exposures in the legalized cannabis industry.</p><p><strong>Methods: </strong>Using data from four state-based surveillance systems (California, Massachusetts, Michigan, and Washington), WRA cases within the cannabis industry were identified and classified as new-onset asthma or work-aggravated asthma.</p><p><strong>Results: </strong>From legalization dates (1996 in California, 2012 in Massachusetts, 2008 in Michigan, 1998 in Washington) through 2023, 30 WRA cases were identified. A majority were aged 18 to 34 years (66.7%) and were male (60%). Thirteen (52%) cases were new-onset asthma, and 12 (48%) were work-aggravated asthma, with two fatalities. The most frequently reported exposure was plant materials (40.4%), of which 94.7% were cannabis dust and/or marijuana plant. Most cases (69%) worked in indoor cultivation/processing.</p><p><strong>Conclusions: </strong>Cannabis industry workers are at risk for WRA, emphasizing the need for interventions to address workplace respiratory hazards.</p>","PeriodicalId":94100,"journal":{"name":"Journal of occupational and environmental medicine","volume":" ","pages":"862-868"},"PeriodicalIF":1.4000,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of occupational and environmental medicine","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1097/JOM.0000000000003461","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/6/3 0:00:00","PubModel":"Epub","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Objective: Describe work-related asthma (WRA) cases and associated exposures in the legalized cannabis industry.
Methods: Using data from four state-based surveillance systems (California, Massachusetts, Michigan, and Washington), WRA cases within the cannabis industry were identified and classified as new-onset asthma or work-aggravated asthma.
Results: From legalization dates (1996 in California, 2012 in Massachusetts, 2008 in Michigan, 1998 in Washington) through 2023, 30 WRA cases were identified. A majority were aged 18 to 34 years (66.7%) and were male (60%). Thirteen (52%) cases were new-onset asthma, and 12 (48%) were work-aggravated asthma, with two fatalities. The most frequently reported exposure was plant materials (40.4%), of which 94.7% were cannabis dust and/or marijuana plant. Most cases (69%) worked in indoor cultivation/processing.
Conclusions: Cannabis industry workers are at risk for WRA, emphasizing the need for interventions to address workplace respiratory hazards.